Impact of cell-proliferation-associated gene expression on 2-deoxy-2-[ 18F]fluoro-D-glucose (FDG) kinetics as measured by dynamic positron emission tomography (dPET) in Colorectal Tumors

Molecular Imaging and Biology

Volumn 13, Issue 6, 2011, Pages 1290-1300

  Strauss, Ludwig G ^a   Koczan, Dirk ^b   Klippel, Sven ^c   Pan, Leyun ^a   Cheng, Caixia ^a   Haberkorn, Uwe ^a,d   Willis, Stefan ^c   Dimitrakopoulou Strauss, Antonia ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c KLINIKUM LUDWIGSHAFEN   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cell cycle; FDG; Gene array; Gene expression; PET; Proliferation

Indexed keywords

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; COLORECTAL TUMOR; CONTROLLED STUDY; CYCLIN D2 GENE; CYCLIN DEPENDENT KINASE 2 GENE; CYCLIN DEPENDENT KINASE 6 GENE; CYCLIN DEPENDENT KINASE INHIBITOR 1C GENE; CYCLIN DEPENDENT KINASE INHIBITOR 2B GENE; CYCLIN G2 GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REGULATOR GENE; TRANSPORT KINETICS;

BIOLOGICAL TRANSPORT; BLOOD VOLUME; CELL PROLIFERATION; COLORECTAL NEOPLASMS; CYCLIN D2; CYCLIN-DEPENDENT KINASE 2; FLUORODEOXYGLUCOSE F18; FRACTALS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; LINEAR MODELS; POSITRON-EMISSION TOMOGRAPHY;

EID: 84855715906     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-010-0465-z     Document Type: Article

References (28)

1. Strauss LG, Conti PS (1991) The applications of PET in clinical oncology. J Nucl Med 32:623-648
2. Higashi K, Clavo AC, Wahl RL (1993) Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med 34:414-419 (Pubitemid 23075381)
3. Tateishi U, Yamaguchi U, Seki K, Terauchi T, Arai Y, Hasegawa T (2006) Glut-1 expression and enhanced metabolism are associated with tumour grade in bone and soft tissue sarcomas: A prospective evaluation by [18F] fluorodeoxyglucose positron emission tomography. Eur J Nucl Med Mol Imaging 33:683-691 (Pubitemid 43846759)
4. Vesselle H, Schmidt RA, Pugsley JM et al (2000) Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res 6:3837-3844
5. Pugachev A, Ruan S, Carlin S et al (2005) Dependence of FDG uptake on tumour microenvironment. Int J Radiat Oncol Biol Phys 62:545-553 (Pubitemid 40704474)
6. Strauss LG, Klippel S, Pan L, Schönleben K, Haberkorn U, Dimitrakopoulou-Strauss A (2007) Assessment of quantitative FDG PET data in primary colorectal tumours: Which parameters are important with respect to tumour detection? Eur J Nucl Med Mol Imaging 34:868-877 (Pubitemid 46798955)
7. Burt BM, Humm JL, Kooby DA et al (2001) Using positron emission tomography with [18F]FDG to predict tumour behavior in experimental colorectal cancer. Neopasia 3:189-195 (Pubitemid 32747567)
8. Dimitrakopoulou-Strauss A, Strauss LG, Schwarzbach M et al (2001) Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: Impact on diagnosis and correlation with grading. J Nucl Med 42:713-720 (Pubitemid 32453458)
9. Strauss LG, Dimitrakopoulou-Strauss A, Koczan D et al (2004) 18FFDG kinetics and gene expression in giant cell tumours. J Nucl Med 45:1528-1535 (Pubitemid 47618507)
10. Strauss LG, Koczan D, Klippel S et al (2008) Impact of angiogenesisrelated gene expression on the tracer kinetics of 18F-FDG kinetics in colorectal tumours. J Nucl Med 49:1238-1244
11. Ohtake T, Kosaka N, Watanabe T, Yokoyama I, Moritan T, Masuo M et al (1991) Noninvasive method to obtain input function for measuring glucose utilization of thoracic and abdominal organs. J Nucl Med 32:1432-1438
12. Pan L, Mikolajczyk K, Strauss LG, Haberkorn U, Dimitrakopoulou- Strauss A (2007) Machine learning based parameter imaging and kinetic modeling of PET data [abstract]. J Nucl Med 48(suppl):158P
13. Dimitrakopoulou-Strauss A, Strauss LG, Mikolajczyk K, Burger C, Lehnert T, Bernd LG, Ewerbeck V (2003) On the fractal nature of dynamic positron emission tomography (PET) studies world. J Nucl Med 2:306-313
14. Strauss LG, Pan L, Koczan D et al (2007) Fusion of positron emission tomography (PET) and gene array data: A new approach for the correlative analysis of molecular biological and clinical data. IEEE Trans Med Imag 26:804-812 (Pubitemid 46842915)
15. Wunder JS, Paulian G, Huyos AG, Heller G, Meyers PA, Healey JH (1998) The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma. J Bone Joint Surg Am 80:1020-1033 (Pubitemid 28355673)
16. Zhang J, Kang SK, Wang L, Touijer A, Hricak H (2009) Distribution of renal tumour growth rates determined by using serial volumetric CT measurements. Radiology 250:137-144
17. Goh V, Halligan S, Daley F, Wellsted DM, Guenther T, Bartram CT (2008) Colorectal tumour vascularity: Quantitative assessment with multidetector CT-do tumour perfusion measurements reflect angiogenesis? Radiology 249:910-917
18. Schiepers C, Chen W, Dahlbom M, Cloughesy T, Hoh CK, Huang SC (2007) 18F-fluorothymidine kinetics of malignant brain tumours. Eur J Nucl Med Mol Imaging 34:1003-1111
19. Dimitrakopoulou-Strauss A, Strauss LG (2008) The role of 18 F-FLT in cancer imaging: Does it really reflect proliferation? Eur J Nucl Med Mol Imaging 35:523-526
20. Riedl CC, Akhurst T, Larson S et al (2007) 18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastases. J Nucl Med 48:771-775 (Pubitemid 47604978)
21. Buck AK, Halter G, Schirrmeister H et al (2003) Imaging proliferation in lung tumours with PET: 18F-FLT versus 18F-FDG. J Nucl Med 44:1426-1431 (Pubitemid 39663355)
22. Henriksson E, Kjellén E, Baldetorp B et al (2009) Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck. J Exp Clin Cancer Res 28:17. doi:10.1186/1756-9966- 28-17
23. Sánchez Salmóna A, Garridoa M, Abdulkaderb I, Gudec F, Leónd L, Ruibala A (2009) The immunohistochemical expression of cyclinB1 is associated with higher maxSUV in 18F-FDG-PET in nonsmall cell lung cancer patients. Initial results. Rev Esp Med Nucl 28:63-65
24. Zhou YL, Deng CS (2005) Correlations of expressions of Glut1 and HIF-1alpha to cellular proliferation of colorectal adenocarcinoma. Ai Zheng 24:685-689
25. Sakamaki T, Casimiro MC, Ju X et al (2006) Cyclin D1 determines mitochondrial function in vivo. Mol Cell Biol 26:5449-5469 (Pubitemid 44036212)
26. +/PKC, MAPKs and HIF-1alpha. Cell Physiol Biochem 19:269-282 (Pubitemid 46701502)
27. Strauss LG, Dimitrakopoulou-Strauss A, Haberkorn U (2003) Shortened PET data acquisition protocol for the quantification of 18F-FDG kinetics. J Nucl Med 44:1933-1939 (Pubitemid 40022139)
28. Strauss LG, Pan L, Cheng C, Haberkorn U, Dimitrakopoulou-Strauss A (2009) Accuracy of shortened acquisition protocols for the quantitative assessment of the 2-tissue compartment method using dynamic PET F-18-deoxyglucose (FDG) studies. [abstract]. J Nucl Med 50(2):630